University of British Columbia

Recent Events

News & Analysis

dr. and university of british columbia - All News and Analysis

• Fox Resources Completed QT, Financings and Name Change

  - 2008-08-18

  Fox Resources Ltd. (formerly Waverley Biotech Inc.) ("Fox" or the "Company") (TSX VENTURE: FAX) is pleased to announce that it obtained the final approval from the TSX Venture Exchange (the "Exchange") on its Qualifying Transaction (the "QT"), the financings and the name change. The Otter Gold Property The...

  Tags: Company, Dr., Fax, FINANCE, financing, Investment, University of British Columbia

• GeNOsys Announces Service Contract with the University of British Columbia

  - 2008-06-24

  PROVO, Utah -- GeNOsys, Inc. (OTCBB: GNYS) today announced the signing of a Service Contract with the University of British Columbia ("UBC"). The Service Contract is for a period of one year. Under the Service Contract, UBC will conduct research at the UBC Department of Medicine, and the Vancouver Coastal...

  Tags: bacteria, Dr., HARDWARE, Tablets, University of British Columbia

• EnWave Files bioREV Equipment and Methodology Patent for Vaccine Dehydration.

  - 2007-09-14

  VANCOUVER, BRITISH COLUMBIA, Sep 14, 2007 CCNMatthews via COMTEX -- EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave" or "the Company") wishes to report that Dr. Tim Durance and EnWave Senior Engineer Leon Fu have filed a US patent application on behalf of EnWave to protect the Company's ...

  Tags: Company, Dr., HEALTHCARE, patent, University of British Columbia, vaccine

• Northern Abitibi Appoints Vice President of Exploration.

  - 2007-05-09

  CALGARY, ALBERTA, May 9, 2007 CCNMatthews via COMTEX -- Northern Abitibi Mining Corp. (TSX VENTURE:NAI) ("Northern Abitibi") is pleased to announce the appointment of Dr. Stephen Rowins as the new Vice President Exploration for the company. Dr. Rowins has 20 years of diverse experience...

  Tags: Dr., FINANCE, INTERNET, University of British Columbia

• EnWave Corporation: Vaccine, Drug Process Patents Filed.

  - 2007-02-22

  VANCOUVER, BRITISH COLUMBIA, Feb 22, 2007 CCNMatthews via COMTEX -- EnWave Corporation (TSX VENTURE:ENW) (the "Company") wishes to report that Dr. Tim Durance, in conjunction with other researchers at the University of British Columbia UBC, has filed US CIP and international PCT patent applications to protect...

  Tags: Company, Dr., HEALTHCARE, patent, technology, University of British Columbia, vaccine

• MIV Therapeutics Highlights 2005 Scientific and Strategic Milestones in Development of New Generation Biomedical Technologies; Year-End Report Cites Achievements in Breakthrough Drug Delivery and Other Solutions for Multi-Billion-Dollar Markets

  - 2006-01-04

  VANCOUVER, British Columbia -- MIV Therapeutics, Inc. (OTCBB:MIVT) (FWB:MIV), a leading developer of next-generation biocompatible coatings and advanced drug delivery systems, has reported significant progress in a report outlining the achievement of numerous key strategic, corporate and technological objectives for 2005. "The past year has been a time of...

  Tags: Benefits, biomedical, Company, conference, Dr., Engineering, HEALTHCARE, R&D, SOFTWARE, technology, University of British Columbia

• Meridian Receives Endorsement from Recognised Cardiologist for Digital Pulse Analyzer

  - 2005-12-01

  SEOUL, Korea -- Meridian Co., Ltd. ("Meridian") (OTCBB:MRDAF) announced today that it has received a positive endorsement of its Digital Pulse Analyzer product from Dr. Saul Isserow. The study performed by Dr. Isserow was undertaken completely independently without any input or influence by any Meridian Co., Ltd....

  Tags: Benefits, Company, Dr., HEALTHCARE, SOFTWARE, University of British Columbia

• Meridian Receives Endorsement from Recognised Cardiologist for Digital Pulse Analyzer.

  - 2005-12-01

  SEOUL, KOREA, Dec 1, 2005 CCNMatthews via COMTEX -- Meridian Co., Ltd. ("Meridian") (OTCBB:MRDAF) announced today that it has received a positive endorsement of its Digital Pulse Analyzer product from Dr. Saul Isserow. The study performed by Dr. Isserow was undertaken completely independently without any input...

  Tags: Benefits, Company, Dr., HEALTHCARE, SOFTWARE, University of British Columbia

• MIV Therapeutics' Passive Stent Coatings Accepted for Presentation at Prestigious World Conference on Cardiovascular Therapy; Interim Results of Animal Trials of Proprietary HAp Coating to be Detailed at TCT 2005 Conference

  - 2005-09-12

  VANCOUVER, British Columbia -- MIV Therapeutics, Inc. (OTCBB:MIVT), a developer of next-generation biocompatible stent coatings and drug delivery technologies for the treatment of cardiovascular disease, announced that interim results of a long-term animal study of its proprietary ultra-thin Hydroxyapatite coating will be featured at this year's 17th annual Transcatheter Cardiovascular...

  Tags: abstract, Benefits, Company, conference, Dr., HEALTHCARE, SOFTWARE, technology, University of British Columbia

• Implications of an Asian Dust Storm on the Gulf of Alaska

  - 2005-09-01

  Far-Reaching Effects of Dust Storms on the Trace Metal Supply And the Biological Consequences for the Gulf of Alaska In April 2001, a large dust storm occurred in the Gobi and Takla Makan deserts. The resulting dust cloud traveled east over the Pacific Ocean, extending from the Hawaiian...

  Tags: Alaska, Aluminum, cadmium, Dr., Gulf, Iron, NETWORKING, North, particle, Peterson, satellite, University of British Columbia